WENTWORTH KORY JAMES (Chief Financial Officer) sold 2.1% of their position (2.50K shares) of ENTRADA THERAPEUTICS, INC. on the open market
Open‑market sale worth $32.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/2/2026ACC: 0001725663-26-000005
Officer· Chief Financial Officer
Since Oct 2021
-2.50K
Net shares
Net seller
$32.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.50K
Price / share
$12.95
Trade value
$32.38K
% of position
2.1%
4/1/2026
121.51K→119.01K
Total
Net shares
−2.50K
Net value
-$32.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | S · Sale | −2.50K | $12.95 | $32.38K | 2.1% | 121.51K | 119.01K |
| Total | −2.50K | -$32.38K | ||||||
Derivative Transactions0
No derivative transactions reported